Immunofluorescence Study on Thrombolysis with Special Reference to the Patterns of Distribution and the Contents of Fibrin, Plasminogen, α₂-Macroglobulin and Urokinase in Artificial Thrombi

Summary

By the immunofluorescence technique, fibrin, plasminogen and α₂-macroglobulin demonstrated a similar basic pattern of distribution in the artificial thrombi, rimming the platelet aggregates in the white part and forming a network structure in the red part. The content of plasminogen seemed to be higher in the red part than in the white part. After superfusion with urokinase solution, urokinase was found in a similar pattern of distribution to that of fibrin. The content of urokinase seemed to be higher in the red part, especially in its outer area, than in the white part. It is concluded that urokinase diffused into the artificial thrombi can convert plasminogen, trapped onto fibrin threads to plasmin. Poor lysibility of the white part might be due to thick strands of fibrin, a low content of plasminogen and a low diffusibility of plasminogen activator, in addition to the antifibrinolytic activity of platelets.

• References

• 1 Alkjaersig N, Fletcher AP, Sherry S. 1959; The mechanism of clot dissolution by plasmin. Journal of Clinical Investigation 38: 1086
• 2 Chandler AB. 1958; In vitro thrombotic coagulation of the blood. Laboratory Investigation 7: 110
• 3 Chesterman CN, Allington MJ, Sharp AA. 1972; Relationship of plasminogen activator to fibrin. Nature New Biology 238: 15
• 4 Dalal PM, Shah PM, Allington MJ, Sharp AA. 1969; Activator of plasminogen in saline extracts of human thrombi. Nature 222: 988
• 5 Fearnley GR. 1953; Fibrinolysis by adsorption. Nature 172: 544
• 6 Gottlob R, Blümel G. 1968; Studies on thrombolysis with streptokinase. I. On the penetration of streptokinase into thrombi. Thrombosis et Diathesis Haemorrhagica 19: 94
• 7 Gottlob R, El Nashef B, Donas P, Piza F, Kolb R. 1973; Studies of thrombolysis with streptokinase. IV. Immunofluorescent investigations on the fibrin pattern and the content of plasminogen and plasma-plasmin-inhibitors in clots and thrombi of various age.. Thrombosis et Diathesis Haemorrhagica 29: 393
• 8 Hisano S, Kawai N, Tanaka K. 1976; Studies on thrombolysis. Blood and Vessels 7: 392
• 9 Jacobsen CD, Chandler AB. 1965; Thrombolysis in vitro I. Method comparison of various thrombolytic agents and factors influencing thrombolysis. Scandinavian Journal of Clinical Laboratory Investigation 17 (Suppl. 84) 209
• 10 Jacobsen CD, Chandler AB. 1965; Thrombolysis in vitro II. Thrombolytic effect of streptokinase and urokinase in health and disease. Scandinavian Journal of Clinical Laboratory Investigation 17 (Suppl. 84) 225
• 11 Johnson SA, Schneider CL. 1953; The existence of antifibrinolytic activity in platelets. Science 117: 229
• 12 Lassen M. 1958; Adsorption of plasminogen activator to fibrin. Acta chemica scandinavica 12: 1825
• 13 Lawson DH, Hutton MM, McNicol GP. 1973; Chandler’s thrombi as agents for the assessment of antithrombotic drugs in vitro. Journal of Clinical Pathology 26: 452
• 14 McNicol GP, Bain WH, Walker F, Rifkind BM, Douglas AS. 1965; Thrombolysis studied in an artifical circulation. Thrombi prepared in vitro in a Chandler’s tube. Lancet I: 838
• 15 Moore S, Pepper DS, Cash JD. 1975; The isolation and characterization of a platelet-specific β-globulin (β-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets. Biochimica et biophysica acta 379: 360
• 16 Ogston CM, Ogston D, Fullerton HW. 1968; Observation on the lysis of artificial thrombi by urokinase. Thrombosis et Diathesis Haemorrhagica 19: 107
• 17 Tanaka K. 1968; Thrombosis. Fukuoka Acta Medica 59: 337